January 20, 2021
Ethics in Whole Genome Sequencing
By Toni Lewis
The use of whole-genome sequencing (WGS) in diagnostic testing brings up the topic of secondary findings or incidental findings
for many clinicians. Secondary findings are variants associated
with a condition other than the one for which the patient is tested.
For instance, if a newborn baby has a suspected illness detected
on prenatal ultrasound and the infant is tested – would it be ethical
for a clinician to disclose other medical conditions that the child
may experience as an adult?
Read the full article at Neonatology Today. Scroll to page 72.
« Variantyx Surpasses 2,500 Genomes Analyzed, Highlights the Value of Its WGS-Based Testing Methodology